Risperdal is an antipsychotic medication that is manufactured by Janssen Pharmaceuticals, which is owned by Johnson & Johnson. Also known by its generic name risperidone, this antipsychotic drug is typically used in the treatment of schizophrenia in adolescents and adults. It changes how the chemicals in the brain work. However, it is also used in the treatment of other disorders as well. Risperdal has been instrumental in treating attention deficit hyperactivity disorder (ADHD), which is formerly known as attention deficit disorder (ADD). It has also been effective in the treatment of autism in children. Plus, approval was given for Risperdal to be used in the treatment of irritability in children who are ages 5 to 16 years old.

Risperdal has been a rather lucrative medication. It reached its pinnacle in 2007 when sales rose in excess of $4.5 billion. By 2012, sales had declined to only $358 million. Losing its patent protection played a role in this decline.

Risperdal usage by boys and young men had been linked to increased levels of prolactin. Prolactin is a hormone that causes gynecomastia, which involves the growth of breasts and the production of breast milk. Warnings had been issued by the U.S. Food and Drug Administration (FDA) regarding the connection between Risperdal usage and gynecomastia.

In the United States, Johnson & Johnson has been named in more than 400 lawsuits regarding injuries that were sustained due to Risperdal usage. These lawsuits contend that Johnson & Johnson participated in the illegal marketing of Risperdal. The primary side effect most often cited in these lawsuits is the appearance of abnormal-looking, feminine-like breasts on the chests of young men. Sometimes the said breasts emitted a discharge and developed enlarged nipples.

According to these lawsuits, Johnson & Johnson allegedly had knowledge of the link between Risperdal and gynecomastia, but they deliberately concealed it from the public. Plus, claims had been made that prolonged usage of Risperdal had been associated with the increased risks of the following: pancreatitis, cellulitis, stroke, bone loss, diabetes, pituitary tumors, heart attack, sudden weight gain, neutropenia and suicide or suicidal notions.

A lawsuit was filed against Janssen and Johnson & Johnson by the State of Louisiana. It contended that the public was misled in the way in which the companies marketed Risperdal. According to the lawsuit, physicians were deliberately lured into prescribing the medication although safer and less costly alternative drugs were available on the market. This lawsuit resulted in a verdict against Janssen and Johnson & Johnson in 2013. And, the State of Louisiana was awarded a staggering amount of $257 million. However, later in 2014, the verdict was overturned by the Louisiana Supreme Court. On a separate note, Johnson & Johnson did settle another lawsuit involving Risperdal marketing allegations for $2.2 million. This lawsuit was filed by the U.S. Department of Justice.

There are more than 200 consolidated court cases that are awaiting adjudication in the state courts of Pennsylvania. These cases also allege that Risperdal is a dangerous medication that was injurious to the patients who were supposed to receive the most benefit from it. The premise is that these patients could have prescribed a safer and more effective alternative drug.

Many people have suffered from the side effects of Risperdal. The lawyers at Zayed Law Offices have spoken to many of them who, although they used Risperdal for only a short period of time, are battling gynecomastia.

In 2012, an injury case involving Risperdal usage was settled by Johnson & Johnson. In that particular case, injury was claimed by a male patient who developed female breasts. He had been taking Risperdal for only five years.

Perhaps you have been injured as a result of taking Risperdal. And, as a result, you have lost time from work and have accumulated medical bills. Should you not be compensated for such? Should you not be compensated for your pain and suffering? The pharmaceutical industry is a multibillion dollar industry. Should pharmaceutical companies not be held accountable? The lawyers at Zayed Law Offices will help you in your quest for fair compensation. Our sound knowledge of the pharmaceutical defective drug world will help you to maneuver your case through the court system and toward a resolution that is most beneficial for you.